Alerts will be sent to your verified email
Verify Email
SURAKSHA
|
Suraksha Diagnostic
|
Dr. Lal Pathlabs
|
Metropolis Health.
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
10.67 % | 20.49 % | 17.42 % |
|
5yr Avg Net Profit Margin
|
8.42 % | 16.53 % | 13.94 % |
|
Price to Book
|
7.31 | 12.61 | 8.37 |
|
P/E
|
46.4 | 53.41 | 73.21 |
|
5yr Avg Cash Conversion Cycle
|
-146.25 Days | -128.38 Days | -103.57 Days |
|
5yr Average Interest Coverage Ratio
|
6.53 | 19.96 | 11.6 |
|
5yr Avg ROCE
|
13.25 % | 26.99 % | 18.91 % |
|
5yr Avg Operating Profit Margin
|
25.19 % | 26.87 % | 25.91 % |
|
5 yr average Debt to Equity
|
0.09 | 0.08 | 0.08 |
|
5yr CAGR Net Profit
|
37.65 % | 10.81 % | -4.56 % |
|
5yr Average Return on Assets
|
7.06 % | 15.26 % | 10.32 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
48.88 % | 53.79 % | 48.89 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 1.18 % |
|
Change in Promoter Holding (3 Yrs)
|
-14.08 % | -1.26 % | -0.9 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
19.58 % | 12.21 % | 17.05 % |
|
Suraksha Diagnostic
|
Dr. Lal Pathlabs
|
Metropolis Health.
|
|---|